| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Thye Dirk | CEO and CMO, Director | C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO | /s/ Brendan Hannah as attorney-in-fact for Dirk Thye | 11 Dec 2025 | 0001638945 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QNCX | Common Shares | Gift | $0 | -739,885 | -74% | $0.000000 | 255,000 | 10 Dec 2025 | Direct | |
| transaction | QNCX | Common Shares | Gift | $0 | +739,885 | $0.000000 | 739,885 | 10 Dec 2025 | Thye Trust |